Download PDF
CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2015; 6(04): 163-168
DOI: 10.4103/0976-5042.173962
Original Article
Journal of Digestive Endoscopy

Post-ERCP pancreatitis and its related factors: A prospective study in Cipto Mangunkusumo National General Hospital

Dadang Makmun
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
,
Murdani Abdullah
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
,
Ari Fahrial Syam
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
,
Achmad Fauzi
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
› Author Affiliations
Further Information

Publication History

Publication Date:
01 October 2019 (online)

Also available at
  PDF Download Permissions and Reprints

Abstract

Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is a widely used procedure for the diagnosis and treatment of pancreatobiliary disease with post-ERCP pancreatitis (PEP) is the most common complication. The goal of this study was to comprehensively evaluate the potential patient- and procedure-related risk factors for PEP. Methods: A 25-variable database was compiled from information collected before, during, and 24-72 h after ERCP for 238 patients who underwent diagnostic or therapeutic ERCP in Cipto Mangunkusumo General National Hospital, Jakarta. The grading of acute pancreatitis was classified using the modified Glasgow (Imrie′s) severity criteria. Results: The average age was 51 years, and most patients were men and were overweight. Sixty-three patients (26.5%) were diagnosed with PEP, and 33 of these (52.4%) were classified as having severe pancreatitis. We applied univariate analysis to analyze the data contained in the 25-variable database to identify patient- and procedure-related predictors of PEP. We found significant correlations between PEP and the patient-related factor common bile duct stenosis (P < 0.05), and between PEP and the three procedure-related factors procedure time, cannulation time, and multiple cannulation attempts (P < 0.05). Multivariate analysis showed that multiple attempts at cannulations was the only significant risk factor for PEP. Conclusions: In our study, four variables were associated with PEP: Common bile duct stenosis, procedure time, cannulation time, and multiple attempts at cannulations. We conclude that, in patients undergoing ERCP who are at high risk of PEP, procedure-related factors should be monitored to reduce the risk of PEP. Multiple attempts at cannulation was the most significant risk factor in our study.

Key words

Endoscopic retrograde cholangiopancreatography - pancreatitis - postendoscopic retrograde cholangiopancreatography pancreatitis - risk factors
 

  • References

  • 1 Arata S, Takada T, Hirata K, Yoshida M, Mayumi T, Hirota M, et al. Post-ERCP pancreatitis. J Hepatobiliary Pancreat Sci 2010;17:70-8.
  • 2 Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, et al. Incidence rates of post-ERCP complications: A systematic survey of prospective studies. Am J Gastroenterol 2007;102:1781-8.
  • 3 Lazaraki G, Katsinelos P. Prevention of post ERCP pancreatitis: An overview. Ann Gastroenterol 2008;21:27-38.
  • 4 ASGE Standards of Practice Committee, Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V, et al. Complications of ERCP. Gastrointest Endosc 2012;75:467-73.
  • 5 Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379-400.
  • 6 Barreto SG, Rodrigues J. Comparison of APACHE II and Imrie Scoring Systems in predicting the severity of acute pancreatitis. World J Emerg Surg 2007;2:33.
  • 7 Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Risk factors for post-ERCP pancreatitis: A prospective multicenter study. Am J Gastroenterol 2006;101:139-47.
  • 8 Wang P, Li ZS, Liu F, Ren X, Lu NH, Fan ZN, et al. Risk factors for ERCP-related complications: A prospective multicenter study. Am J Gastroenterol 2009;104:31-40.
  • 9 Williams EJ, Taylor S, Fairclough P, Hamlyn A, Logan RF, Martin D, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007;39:793-801.
  • 10 Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: A multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009;70:80-8.
  • 11 Feurer ME, Adler DG. Post-ERCP pancreatitis: Review of current preventive strategies. Curr Opin Gastroenterol 2012;28:280-6.
  • 12 Behlül B, Ayfer S, Sezgin V, Altay K, Mustafa C, Cem C, et al. Safety of endoscopic retrograde cholangiopancreatography in patients 80 years of age and older. Prz Gastroenterol 2014;9:227-31.
  • 13 Lukens FJ, Howell DA, Upender S, Sheth SG, Jafri SM. ERCP in the very elderly: Outcomes among patients older than eighty. Dig Dis Sci 2010;55:847-51.
  • 14 Freeman ML. Post-ERCP pancreatitis: Patient and technique-related risk factors. JOP 2002;3:169-76.
  • 15 Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001;54:425-34.
  • 16 Deenadayalu VP, Blaut U, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis? A retrospective, multicenter study. J Clin Gastroenterol 2008;42:1103-9.
  • 17 Kumar N, Gergi MA, Thompson CC. Obesity is an independent risk factor for post-ERCP pancreatitis: Results of a nationwide database analysis. Gastrointest Endosc 2012;75:142.
  • 18 Sultan S, Baillie J. What are the predictors of post-ERCP pancreatitis, and how useful are they? JOP 2002;3:188-94.
  • 19 Nader F, Magdey A, Mossalam H, Rashad FE. Risk factors of post-ERCP pancreatitis. AAMJ 2007;5:36-44.
  • 20 Sekimoto M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN Guidelines for the management of acute pancreatitis: Epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:10-24.
  • 21 Kadayifci A. Risk factors for post-ERCP pancreatitis. Endoscopy 2008;40:81.
  • 22 Testoni PA, Mariani A, Giussani A, Vailati C, Masci E, Macarri G, et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: A prospective multicenter study. Am J Gastroenterol 2010;105:1753-61.
  • 23 Wang ZK, Yang YS, Cai FC, Wang YH, Shi XL, Ding C, et al. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial. Chin Med J (Engl) 2013;126:2403-8.
  • 24 Ozaslan E. Difficult cannulation is the most important factor for post-ERCP pancreatitis: What is the mechanism? Gastrointest Endosc 2013;77:313-4.
  • 25 Maydeo A, Bhandari S, Singh H. Access (precut) sphincterotomy: Conceptual philosophy and technical details. In: Baron TH, Fasge F, editors. ERCP. New York: Elsevier Science Publishing Company, Inc.; 2008. p. 86-90.
  • 26 Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: A comprehensive review. Gastrointest Endosc 2004;59:845-64.
  • 27 Jeurnink SM, Siersema PD, Steyerberg EW, Dees J, Poley JW, Haringsma J, et al. Predictors of complications after endoscopic retrograde cholangiopancreatography: A prognostic model for early discharge. Surg Endosc 2011;25:2892-900.
  • 28 Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: A meta-analysis. Endoscopy 2003;35:830-4.
  • 29 Bhasin DK, Rana SS, Nadkarni N. Protocol-based management strategy for post-endoscopic retrograde cholangiopancreatography pancreatitis: Can it make a difference? J Gastroenterol Hepatol 2008;23:344-7.
  • 30 Pezzilli R, Morselli-Labate AM, Corinaldesi R. NSAIDs and acute pancreatitis: A systematic review. Pharmaceuticals 2010;3:558-71.
  • 31 Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366:1414-22.
  • 32 Cheung J, Tsoi KK, Quan WL, Lau JY, Sung JJ. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: A systematic review and meta-analysis. Gastrointest Endosc 2009;70:1211-9.
  • 33 Donnellan F, Byrne MF. Prevention of post-ERCP pancreatitis. Gastroenterol Res Pract 2012;2012:796751.
  • 34 Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, et al. Prophylaxis of post-ERCP pancreatitis: European society of gastrointestinal endoscopy (ESGE) Guideline-updated June 2014. Endoscopy 2014;46:799-815.
  • 35 Choudhary A, Bechtold ML, Arif M, Szary NM, Puli SR, Othman MO, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: A meta-analysis and systematic review. Gastrointest Endosc 2011;73:275-82.